RaySearch Laboratories AB (publ) (RSLBF)

Market Cap	883.81M
Revenue (ttm)	107.71M
Net Income (ttm)	18.39M
Shares Out	n/a
EPS (ttm)	0.54
PE Ratio	48.06
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,300
Average Volume	198
Open	23.90
Previous Close	23.90
Day's Range	22.50 - 24.00
52-Week Range	8.33 - 26.74
Beta	1.15
RSI	43.82
Earnings Date	Apr 25, 2025

About RaySearch Laboratories AB

RaySearch Laboratories AB (publ), a medical technology company, provides software solutions for cancer care in the Americas, Europe, Africa, the Asia-Pacific, and the Middle East. It develops and markets RayStation, a treatment planning system for radiation therapy; RayCare, an oncology information system that manages clinical activities; RayIntelligence, a cloud-based analytics system for monitoring and enhancement of cancer therapy; and RayCommand, a treatment control system that serves as link between the treatment machine and the treatment ...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1988
• Employees: 416
• Stock Exchange: OTCMKTS
• Ticker Symbol: RSLBF

Financial Performance

In 2024, RaySearch Laboratories AB's revenue was 1.19 billion, an increase of 16.62% compared to the previous year's 1.02 billion. Earnings were 203.51 million, an increase of 149.49%.

Financial numbers in SEK